BMPR2 and pulmonary arterial hypertension: Among the molecules that play a role in the development of PAH, bone morphogenetic protein receptor type II (BMPRII), a type-II receptor of the TGF-β superfamily, is the most studied and well-established key player in both clinical and laboratory settings13–16.